Skip to main content

and
  1. No Access

    Article

    Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies

    Antibody–drug conjugates (ADCs) represent a crucial component of targeted therapies in gastric cancer, potentially altering traditional treatment paradigms. Many ADCs have entered rigorous clinical trials base...

    Jia-Lin Hao, **n-Yun Li, Yu-Tong Liu, Ji-Xuan Lang, Di-Jie Liu in Gastric Cancer (2024)